Back to search

University of Thessaly (UTH)

Ανάπτυξη και χαρακτηρισμός ξενομοσχευμάτων καρκίνου του παγκρέατος από ασθενείς (patient derived xenografts, PDX) σαν παρακλινικά μοντέλα για τον καρκίνο του παγκρέατος

Abstract

dc:description

Pancreatic cancer (PC) is characterized by an increased incidence and extremely poor prognosis. Therefore, there is a great necessity to identify new biomarkers and develop personalized therapy. In this context, the Patient-Derived Xenografts (PDX) represent a novel and promising preclinical cancer model. PDXs are based on the implantation of cells from the patient's primary tumor into immunocompromised mice. With their ability to mimic the primary tumor microenvironment and highlight clonal heterogeneity, they are emerging as an innovative preclinical platform for studying cancer biology, discovering new biomarkers, and personalized testing of chemotherapeutic drug efficacy.Aquaporins (AQPs) represent a family of proteins with important channel functions, located in the cell membrane, and facilitating the translocation of water. A total of 13 proteins (AQP1-12A, B) are included in the AQP family. AQPs have been investigated for their role in the pathogenesis of various types of cancer, but the study of their role in pancreatic cancer remains limited.In the present Ph.D. thesis, we developed and standardized an orthotopic PDX model of pancreatic cancer in immunocompromised mice. The mouse strains we used were NOD/SCID, NSG, RAG-1, with different levels of immunosuppression per strain. Our results showed that the rate of successful implantation depends on the level of immunodeficiency. NSG mice, characterized by a lack of T, B, and NK cells (triple deficiency), were the most immunodeficient of the three species used in the thesis experiments. These findings highlight the important role of immune surveillance against cancer cells, which represents one of the pillars of cancer.At the same time, this thesis highlighted for the first time a unique genetic signature of 11 genes with differential expression in pancreatic cancer, which are simultaneously prognostic indicators related to patient survival. We also demonstrated the relevant molecular functions and regulatory families of miRNAs. This gene panel can be used in conjunction with existing staging systems to provide improved prognostic information. These data need further investigation and testing in PDX models to fully reveal their involvement in pancreatic cancer.As research into new therapeutic regimens and immunotherapies progresses, the orthotopic PDX models we present in this thesis allow an in-depth evaluation of new drugs in a tumor microenvironment that resembles the patient. Further studies to improve these models are already under development in our laboratory. At the same time, the identification of prognostic markers using in silico techniques allows for their further targeted study in PDX models, in a more cost-effective research approach in terms of time and resources. Finally, the identification of the prognostic role of Aquaporin 7 (AQP7) in pancreatic cancer by our group is the first and only to date recorded in the international literature.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Magouliotis, Dimitrios
  • Μαγουλιώτης, Δημήτριος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53501

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Magouliotis, Dimitrios; Μαγουλιώτης, Δημήτριος. Ανάπτυξη και χαρακτηρισμός ξενομοσχευμάτων καρκίνου του παγκρέατος από ασθενείς (patient derived xenografts, PDX) σαν παρακλινικά μοντέλα για τον καρκίνο του παγκρέατος. University of Thessaly (UTH), 2023. http://hdl.handle.net/10442/hedi/53501